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Summary
Background: Transurethral resection leads to character-
istic histological changes of tissue repair (’TUR cystitis‘),
which also cause non-specific cytological changes. The
aim of this study was to investigate the diagnostic sensi-
tivity and specificity of conventional exfoliative urinary
cytology in diagnosing residual urothelial carcinoma after
differential transurethral resection. Patients and Methods:
417 urinary cytology specimens of all 374 patients under-
going primary (n = 326) or secondary (n = 91) transurethral
resection of urothelial carcinoma of the bladder at our
institution between June 1996 and December 1997 were
examined. The cytology specimens were stained accord-
ing to Papanicolaou’s method. The sensitivity and speci-
ficity of the cytologic diagnosis and of the tumour grading
were compared with histological findings. Results: The
overall sensitivity of urine cytology in tumour detection
was 77.6% for primary lesions and 74.5% in the detection
of residual carcinoma after transurethral resection. The
diagnostic specificity was 77% and 84.3% respectively.
The degree of sensitivity was dependent on tumour
grade and was lower for well differentiated tumours.
After transurethral resection, the sensitivity for grade 
1 residual tumours was 11%, whereas it was 54% for 
grade 1 tumours before primary transurethral resection.
Conclusions: The inflammatory changes following trans-
urethral resection of primary bladder carcinoma cause
reactive cytologic changes that make the diagnosis of
well differentiated residual carcinoma more difficult.
However, urinary cytology after transurethral resection
has the same diagnostic accuracy for medium and poorly
differentiated tumours as before primary resection and
thus remains a very useful diagnostic tool.
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Zusammenfassung
Hintergrund: Transurethrale Resektionen von Blasentu-
moren führen zu histologischen Veränderungen («TUR
Zystitis») im Sinne regenerativer Veränderungen, welche
urinzytologisch zu diagnostischen Fehleinschätzungen
führen können. Das Ziel unserer Untersuchung war der
Vergleich der diagnostischen Sensitivität und Spezifität der
Urinzytologie vor transurethraler Resektion mit der bei
der Diagnose von Residualtumoren nach transurethraler
Resektion. Patienten und Methoden: Untersucht wurden
417 urinzytologische Präparate von allen 374 Patienten,
die in unserer Einrichtung zwischen Juni 1996 und Dezem-
ber 1997 einer primären (n = 326) oder sekundären (n = 91)
transurethralen Resektion von Urothelkarzinomen der
Harnblase unterzogen wurden. Die zytologischen Präpa-
rate wurden nach Papanicolaou gefärbt. Sensitivität und
Spezifität der zytologischen Diagnostik und des Tumor-
gradings wurden mit den histologischen Befunden ver-
glichen. Ergebnisse: Die Sensitivität der Urinzytologie in
der primären Tumorerkennung lag bei 77,6% und die für
die Diagnose von Residualtumoren nach transurethraler
Resektion bei 74,5%. Die diagnostische Spezifität lag bei
77% bzw. 84,3%. Die Sensitivität war abhängig vom Dif-
ferenzierungsgrad der Urothelkarzinome und war bei gut
differenzierten Tumoren am niedrigsten. Nach transure-
thraler Resektion betrug die Sensitivität der zytologischen
Diagnose für G1-Residualtumore lediglich 11%, während
sie für G1-Primärtumore bei 54% lag. Schlußfolgerungen:
Die entzündlichenVeränderungen nach transurethraler Re-
sektion verursachen Veränderungen exfoliierter Urothel-
zellen, welche die zytologische Diagnose von residualen
G1-Tumoren erschweren. Die Diagnose mäßig und
schlecht differenzierter residualer Urothelkarzinome nach
transurethraler Resektion hat dagegen die gleiche Sensi-
tivität und Spezifität wie die bei primärer Untersuchung,
so daß die Urinzytologie auch bei der Diagnose von
Residualtumoren ein wertvolles diagnostisches Verfahren
darstellt.
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Introduction
The routine usage of exfoliative urinary cytology was intro-
duced into clinical urology as a diagnostic method for the
detection of urothelial carcinoma in the 1970s. The method
depends on the fact that the mucosa of the whole urogenital
tract undergoes continuous regeneration and that urothelial
cells are constantly shed into and excreted with the urine. The
same applies to malignant urothelial cells. These exfoliated uro-
thelial cells can be found in normal urine and can be examined
microscopically after staining.
Malignant urothelial cells differ microscopically from normal
urothelial cells in the appearance of their nuclei. This difference
is more pronounced in less differentiated tumour cells.
Urinary cytology is thus a non-invasive method for the primary
diagnosis and the follow-up of superficial urothelial carcinoma,
which is primarily treated by transurethral resection.
The cytologic diagnosis of residual urothelial carcinoma after
transurethral resection has considerable consequences for the
patient, since this will necessitate secondary or tertiary trans-
urethral resection, whereas in the absence of residual tumour,
the patient can be followed routinely. Thus, a reliable negative
cytologic examination after a primary transurethral resection
of a superficial bladder carcinoma may spare the patient a
secondary transurethral resection.
Urinary cytology is a non-invasive and technically simple diag-
nostic method, but does require a certain degree of experience,
and its diagnostic accuracy depends on this as well as on the
quality of staining and the yield of viable urothelial cells.
The examiner-bias of urinary cytology has led to efforts to replace
conventional exfoliative cytology in the diagnosis of bladder
carcinoma by other urine-based laboratory tests. Automated
cytometric methods (e.g. flow cytometry) and immunocyto-
chemical methods are technically more elaborate and have so
far been of value only for research purposes. Several methods
of detecting tumour-associated antigens in the urine have there-
fore been proposed as alternative diagnostic methods (cyto-
keratins, telomerase, NMP-22, bladder tumour antigen). These
methods potentially offer technically simple methods of
screening for bladder carcinoma. Some of these tests are re-
ported to have a high sensitivity but low specificity in the
detection of urothelial cancer [1–3].
In studies of the diagnostic usefulness of the urine-based detec-
tion of tumour-associated antigens, these new methods were
usually compared with conventional urinary cytology. Often the
sensitivity and specificity of cytology reported in such studies
was rather low [1–3] in comparison to earlier investigations
dealing with the diagnostic accuracy of cytology itself [4, 5].
It is only an assumption that standardised technical methods
are more objective and hence more reliable in their results
than urine cytology, only because the human factor has been
reduced. Urine cytology can lead to false-negative, but rarely
to false-positive results.
The value of urinary cytology as a diagnostic method, however,
can only be assessed in large studies where cytology is prac-
tised as a routine technique. As many other diagnostic and
therapeutic methods in medicine, the value of urinary cytologic
diagnosis depends on the long-term diligence with which this
method is practised.
The aim of this study was to establish the diagnostic sensitivity
and specificity of conventional urinary cytology in a large and
representative group of patients before and after transurethral
resection. After the primary transurethral resection of super-
ficial bladder tumours, which is usually done with curative
intent, we routinely perform a secondary transurethral resec-
tion 3–4 weeks after the first resection in order to increase the
likelihood of complete tumour resection.The cytologic diagno-
sis of malignant urothelial cells in the urine of patients after 
a primary transurethral resection with curative intent thus
proves the existence of residual tumour.
The assessment of the diagnostic value of conventional
urinary cytology in diagnosing residual urothelial carcinoma
after transurethral resection is important for two reasons.
First, regenerative changes in the bladder wall following trans-
urethral resection lead to cytological changes and artefacts
which make the accurate cytologic diagnosis more difficult [6].
Second, the primary urinary cytologic diagnosis of patients
referred for surgery with the preliminary diagnosis of a pos-
sible bladder lesion can lead to an examiner bias which can
falsely increase the diagnostic accuracy of the method. After
macroscopically curative transurethral resection of a bladder
lesion, the cytologic examiner will be free from any such bias
so that the diagnostic value of urinary cytology can be objec-
tively assessed when looking at the sensitivity and specificity
of diagnosing residual carcinoma after primary transurethral
resection.
Patients and Methods
Between June 1996 and December 1997, urinary cytology specimens were
obtained from all patients undergoing transurethral resection of bladder
lesions in our department. During this period, 417 transurethral bladder
tumour resections were performed on 374 patients. Of these, 78.1% were
primary transurethral resections (n = 326) while 21.8% were secondary
resections (n = 91).
Of the 374 patients, 74% were males (n = 276) with a mean age of 
68.2 years, and 26% were females (n = 98) with a mean age of 74.1 years.
From all patients, a mid-stream urinary specimen was obtained on the day
of admission and fixed with thiomersale [7]. Cell concentration was
achieved by centrifugation (4 min at 3000 g). From each urine specimen,
two slides were prepared, fixed with alcohol and stained according to the
method described by Papanicolaou [8]. The microscopic cytologic exami-
nation was done by three different staff members of our department.
The primary transurethral resection of suspicious bladder lesions was done
by the so-called differential resection technique: Complete resection of the
exophytic lesion or suspicious mucosal area was followed by separate re-
section of the macroscopically normal margin of the lesion and of the base
of the lesion. Thus, three separate specimens were sent for histologic
examination after each primary transurethral resection. The routine histo-
logical examination of all specimens was done by the Institute of Pathology
at the Technical University, Dresden.
A secondary transurethral resection was routinely performed 3–4 weeks
after the primary resection in all cases where superficial urothelial carci-
noma had been diagnosed by histology after the primary resection, except
for cases of pTa G1 lesions. In all cases where the tumour was seen histo-
logically in the resection margins or the tumour base, or in all cases other
than the exceptions mentioned, a secondary transurethral resection was
also performed.
The statistical methods used are those of standard calculation of means,
sensitivity and specificity [9].
Results
Of the 326 primary transurethral resections, urothelial carci-
noma was diagnosed in 85.3% (n = 278) and a benign histolog-
ical diagnosis was made in 14.7% of cases (n = 48). Tumour
stages and grades based on the histological findings after the
primary resections are given in table 1A. The cytologic diag-
noses and tumour grades in comparison to the histological
findings are given in table 1B.
Thus, in 65/278 cases of histologically proven primary urothelial
carcinoma, urinary cytology did not detect any malignancy.
This corresponds to 23.4% false-negative cytologic findings for
primary bladder tumours in our series.
Of the 159 patients with superficial bladder tumours (pTa 
and pT1), 113 with pT1 tumours were advised to undergo
secondary resection. Of these, 5 were lost to follow-up and
10 patients who presented for secondary resection more than 
8 weeks after the primary resection were excluded from analy-
sis. Another 7 patients had no cytological examination done
prior to secondary resection, so that a total of 91 specimens
from patients before secondary transurethral resection were
included in the analysis. For the secondary transurethral resec-
tions (n = 91), the results of the histological findings and the
comparison between histology and cytology are given in tables
2A and 2B,respectively.Of the remaining 59 patients who were
histologically found to have residual urothelial carcinoma after
the primary transurethral resection, 44 were correctly identi-
fied by cytology preoperatively. 15 out of 59 cases of histologi-
cally proven residual tumour were not identified cytologically,
representing 25.4% false-negative cytologic findings.
The sensitivity of the urinary cytologic diagnosis before and
after transurethral resection was clearly dependent on tumour
grade (table 3). Before the primary resection, 13 of 94 undif-
ferentiated carcinomas (3 of 11 carcinoma in situ and 10 of 83
exophytic G3 tumours) were missed by cytology. The overall
sensitivity in correctly diagnosing G3 bladder carcinoma was
86.1% and markedly higher than for G1 tumours (54.1%) and
G2 tumours (77.9%). Before secondary transurethral resec-
tion, the relationship was similar: The overall sensitivity in the
diagnosis of G3 tumours was 95% (19/20) and for G2 tumours
80% (24/30). However, the diagnostic sensitivity for residual
G1 tumours was only 11% (1/9) and thus markedly lower
compared to the sensitivity in diagnosing primary G1 bladder
carcinoma.
The specificity of urinary cytologic diagnosis in our study
(table 4) was 77% for primary diagnosis (37/48 histologically
benign lesions were correctly diagnosed by cytology). The
specificity of diagnosing residual tumour after transurethral
resection was slightly higher with 84.3% (27/32). The benign
histological findings after primary resection (n = 48) were
chronic inflammation (n = 35), cystic cystitis (n = 8), squamous
cell metaplasia (n = 3) and one each of inverted papilloma and
polypoid hyperplasia. All specimens from the secondary trans-
urethral resection with and without residual carcinoma were
reported to show the typical findings of ‘TUR cystitis’.
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Table 1. Cytological and histological findings from primary transurethral
resections. A: Histological results after primary transurethral resections
(TUR), tumour stage vs. histological grading. B: Comparison of histolo-
gical and cytological grading before primary TURs
A
Stage Grade______________________________________________________________
G1 G2 G3 total
pTa 25 19 2 46
pT1 21 73 19 113
pT2 2 33 40 75
pT3 0 11 22 33
pTIS – – 11 11
Total 48 136 94 278
B
Histology Cytology______________________________________________________________
G1 G2 G3 no tumor total
detected
G1 11 10 5 22 48
G2 22 58 26 30 136
G3 3 19 51 10 83
CIS 0 2 6 3 11
Total 36 89 88 65 278
CIS = Carcinoma in situ.
Table 2. A: Histological findings after secondary transurethral resection,
tumour stage vs. tumour grading. B: Histological grading vs. cytological
grading before secondary transurethral resection
A
Stage Grade______________________________________________________________
G1 G2 G3 total
pTa 4 5 0 9
pT1 5 14 4 23
pT2 0 9 8 17
pT3 0 2 3 5
pTIS – – 5 5
Total 9 30 20 59
B
Histology Cytology______________________________________________________________
G1 G2 G3 no tumor total
detected
G1 0 1 0 8 9
G2 2 18 4 6 30
G3 1 4 9 1 15
CIS 0 1 4 0 5
Total 3 24 17 15 59
Discussion
The first description of the microscopic detection of malignant
urothelial cells in the urine of patients with bladder cancer
dates back to the works of Lambl [10] and Sanders [11] pub-
lished in 1856 and 1864 respectively. Thus, for bladder cancer,
urine cytology predates the histological examination of bladder
biopsies as a diagnostic method. However, urine cytology did
not develop into a routinely useful method until the fundamen-
tal cytologic work of Papanicolaou and Marshall [8], published
in 1945, and has only since then become an established diag-
nostic tool for the diagnosis and follow-up of patients with
bladder carcinoma.
Exfoliative urine cytology is based on the detection of discrete
structural abnormalities (changes in nuclear structure and size)
of cells isolated from their tissue environment. Urine cytology
is neither able to localise a urothelial malignancy nor can it
supply information about tumour stage. However, in contrast
to randomised bladder biopsies, urine cytology is a detection
method for the whole mucosal surface of the urinary tract.
The problems which can lead to errors in the diagnosis lie in
the nature of the material examined, the biological nature of
urothelial carcinoma and in the visual assessment of stained
slides by an examiner.
Since urinary cytology can only assess isolated cells shed into
the urine, the method is more prone to artefacts caused by the
collection, fixation, storage and processing of the material.
Good cytological results require the processing of fresh urine
[7]. Degenerative cell changes through autolysis and bacterial
growth in the urine sample must be avoided. The number of
cells shed with the urine can vary considerably inter- and intra-
individually and also depends on diuresis, therefore cell con-
centration techniques are indispensable.
The nature of bladder carcinoma provides additional problems.
First, highly differentiated superficial bladder tumours (papil-
lomas according to the WHO classification) which are classi-
fied as such by their histologic features, have a cytologically
benign appearance. Well differentiated urothelial carcinomas
(G1) consist of cells with different grades of anaplasia so that
the cytologic picture can vary. Second, the degree of exfoliation
of malignant cells by any urothelial malignancy can also vary,
and the cytologic appearance of cells found in one urine sample
will not always be representative of the underlying tumour.
And third, errors can occur in the assessment of cytological
specimens. Diagnostic mistakes are particularly likely when (i)
too much emphasis is placed on nuclear staining characteristics
in the absence of distinct changes of the quantitative relation
between nuclei and cytoplasm (staining artefacts), (ii) when
the diagnosis of malignancy is based on the interpretation of
cellular aggregates, and (iii) when the cellular atypia due to
regenerative or inflammatory urothelial changes is misinter-
preted. Especially reactive cellular changes can make the cyto-
logic diagnosis of urothelial malignancy difficult. Such non-
specific changes are those seen after intravesical chemo- and
immunotherapy but also inflammatory changes due to other
causes.
Following transurethral resection of a bladder lesion, tissue
regeneration leads to the so-called ‘TUR cystitis’. This reac-
tive-inflammatory response is histologically characterised by
neutrophilic infiltration of the urothelium and smooth muscle
as well as hyperchromatic nuclear urothelial changes with an
increased number of mitotic figures [12]. The changes caused
by a marked TUR cystitis can therefore make the cytological
detection of residual carcinoma more difficult [6].
However, despite all these potential problems, conventional
urinary cytology can diagnose urothelial cancer with a high
degree of sensitivity and specificity. Investigations of the diag-
nostic accuracy of urinary cytology from the 1980s, when this
method received increasing attention, showed a global sensiti-
vity in tumour detection of about 70% with a specificity of
78–95% [4, 5, 13, 14]. The sensitivity found in these studies for
the detection of G1 tumours was around 50%, for G2 lesions
65–80% and for G3 tumours 85–90%. Thus, the diagnostic
accuracy of urine cytology is higher with less differentiated
tumours. It also follows that urine cytology is not reliable as a
routine screening method since G1 lesions can easily remain
undetected.
In several recently published studies looking at the value of
methods for the detection of urinary tumour-associated anti-
gens, these new methods were compared with conventional
urinary cytology in their ability to detect urothelial malignancy
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Table 3. Sensitivity of cytological assessment: Numbers and percentages of
urothelial carcinomas correctly identified by urinary cytology before pri-
mary transurethral resections
Histological Correctly identified by Sensitivity of 
grading cytology cytology, %
Primary TUR
G1 26/48 54.1
G2 106/136 77.9
G3 73/83 87.9
CIS 8/11 72.7
Total 213/278 76.6
Secondary TUR
G1 1/9 11.1
G2 24/30 80.0
G3 14/15 93.3
CIS 5/5 100
Total 44/59 74.5
TUR = Transurethral resections.
Table 4. Specificity of the cytological diagnosis in cases of benign histolo-
gical findings with primary and secondary transurethral resections
Transurethral Cytological G1 G2 G3 Tumours Total
resections diagnosis detected
n / % n
Primary benign 7 4 0 37 / 77 48
histology
Secondary benign 2 3 0 27 / 84.3 32
histology
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cytology in tumour detection in our study was 77.6% for pri-
mary lesions and 74.5% after transurethral resection, with a
specificity of 77% and 84.3% respectively.
Especially the comparison of the results of cytological exami-
nation before the primary and before a secondary trans-
urethral resection allows a reliable assessment of the quality of
the cytologic diagnosis, since, on the one hand, the post-opera-
tive non-specific changes due to TUR cystitis can make the
cytologic assessment more difficult, and, on the other hand, an
examiner bias is largely excluded following a macroscopically
curative primary transurethral resection. The comparability of
the overall sensitivity and specificity in diagnosing urothelial
malignancy under these conditions suggests that these figures
accurately reflect the value of the method.
The standard by which the results of urinary cytology are out
of necessity judged is the result of the histological diagnosis
after transurethral resection of a bladder lesion. It is well
known that the cytological grading of malignant urothelial cells
is subject to a certain degree of error and that well differen-
tiated G1 tumours can be missed by cytological examination in
50% of cases [17]. However, it should be remembered that the
histological grading of urothelial tumours is examiner- and
experience-dependent as well and can vary considerably when
the same histological specimens are examined by different
pathologists [18]. When cytological and histological grading of
urothelial tumours are compared, this bilateral margin of error
must therefore be taken into account, especially since interna-
tionally there are several classifications of histological grading
of urothelial cancer in use.
The agreement between cytological and histological grading in
our series was 86.1% for G3 tumours before primary transure-
thral resection and 95% before a secondary resection. Thus,
poorly differentiated G3 tumours were rarely missed by cyto-
logy. The cytological detection rate was markedly lower for
medium and well differentiated tumours. The poor sensitivity
of only 11% for the diagnosis of residual G1 tumours compared
to a sensitivity of 54.1% for primary G1 tumours can probably
be attributed to the non-specific changes caused by the post-
operative TUR cystitis which was histologically seen in all
specimens from the secondary resections. These post-TUR
changes cause urothelial atypia which mimics the cellular
changes seen with well differentiated tumours.This may lead to
a certain reluctance on the part of the cytological examiners to
make the diagnosis of ‘residual G1 tumour’ in order to avoid
false-positive assessments.
The specificity of urinary cytological diagnosis in our series was
77% before primary and 84.3% before secondary transure-
thral resection. False-positive assessments did not occur in any
case with the diagnosis G3 tumour. The high specificity of
urinary cytology is generally acknowledged [4, 17]. However, a
high specificity of urine cytology of 97% [3] and even 98.9%
[15] is also reported by authors who acknowledge a low sensi-
tivity in their own series. The combination of a low sensitivity
and a simultaneously high specificity of the cytological assess-
ment reported in these studies suggests that mostly poorly
differentiated, cytologically well recognisable tumours were
identified. However, the proportion between sensitivity and
specificity needs to be well balanced when assessing the results
of this method.
In conclusion, in our series urine cytology was found to be a
reliable diagnostic tool for the detection of urothelial carci-
noma. However, the detection rate is lower for well differen-
tiated tumours, and the non-specific changes of TUR cystitis
lead to a rather poor sensitivity in the detection of residual G1
tumours of only 11%. In contrast, the post-operative cytolo-
gical detection of medium and poorly differentiated tumours 
is the same as before primary transurethral resection.
There are few studies looking at the reliability of urinary cyto-
logy following transurethral resection. Müller et al. [6] reported
a decreased accuracy due to TUR cystitis. Our results show that
the artefacts caused by TUR cystitis only affect the diagnostic
accuracy of residual G1 tumours. Badalament et al. [19] used
cytology 3 days after transurethral resection as a predictor of
later tumour recurrence in patients with superficial bladder
tumours, but did not assess the accuracy of their cytology by
other means. In our study, cytology done shortly before a secon-
dary resection was compared with the histological result, thus
allowing a good assessment of the diagnostic accuracy.
Whether the decision to perform a secondary transurethral
resection can be based on post-operative cytology must remain
open to debate at present. Clearly, in cases of G1 tumours this
cannot be recommended. For G2 and G3 tumours, secondary
transurethral resection may be omitted in selected cases and
only if tumour margins and base were free of malignant tissue
at the primary resection and if repeated post-operative cyto-
logical examinations are negative.
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